{
    "clinical_study": {
        "@rank": "28342", 
        "arm_group": {
            "arm_group_label": "proteomic analysis", 
            "arm_group_type": "No Intervention"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to use the proteomic analysis of synovial fluid to perform the\n      comprehensive investigation of the biomarker that will be useful to assign the tratment\n      effectiveness of five weekly intra-articular HA injection."
        }, 
        "brief_title": "Identification and Characterization of the Biomarker in Synovial Fluid for Hyaluronic Acid Therapy in Osteoarthritis", 
        "completion_date": {
            "#text": "May 2009", 
            "@type": "Actual"
        }, 
        "condition": "Osteoarthritis", 
        "condition_browse": {
            "mesh_term": "Osteoarthritis"
        }, 
        "detailed_description": {
            "textblock": "The intra-articular injection with HA is an accepted therapy for OA. However, the exact\n      regulation of HA treatment is unclear. Compared the expression SF proteome from OA patients\n      who received HA/800 treatment or not (post and pre-HA treatment) may be possible to identify\n      the protein that response to the HA treatment and apply this to prognosis of OA. We used\n      two-dimensional difference gel electrophoresis (2D-DIGE) combined with matrix-assisted laser\n      desorption ionization time of light mass spectrometry (MALDI-TOF) to determine the\n      differentially displayed proteins in human SF. Finally, we used Western blotting and ELISA\n      analysis to validate the potential biomarkers."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of osteoarthritis\n\n          -  Accept the intra-articular HA injection therapy\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01813916", 
            "org_study_id": "200804039R"
        }, 
        "intervention": {
            "arm_group_label": "proteomic analysis", 
            "intervention_name": "proteomic analysis", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Hyaluronic Acid"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Osteoarthritis", 
            "synovial fluid", 
            "hyaluronic acid"
        ], 
        "lastchanged_date": "March 14, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Taipei city", 
                    "country": "Taiwan"
                }, 
                "name": "Ccj@Ntu.Edu.Tw"
            }
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_arms": "1", 
        "official_title": "Identification and Characterization of the Biomarker in Synovial Fluid for Hyaluronic Acid Therapy in Osteoarthritis", 
        "overall_official": {
            "affiliation": "National Taiwan University Hospital", 
            "last_name": "Ching-Chuan Jiang, M.D.;Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Taiwan: Department of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "We used two-dimensional difference gel electrophoresis (2D-DIGE) combined with matrix-assisted laser desorption ionization time of light mass spectrometry (MALDI-TOF) to determine the differentially displayed proteins in human synovial fluid.", 
            "measure": "To study the protein expression of synovial fluid for hyaluronic acid therapy in osteoarthritis", 
            "safety_issue": "No", 
            "time_frame": "up to 12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01813916"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Taiwan University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Taiwan University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2008", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}